Assessment of the Need for Provider Education on Screening  for Depression in Patients with Select Dermatologic Problems by Zerhusen, Sarah B.
University of Kentucky 
UKnowledge 
DNP Projects College of Nursing 
2018 
Assessment of the Need for Provider Education on Screening for 
Depression in Patients with Select Dermatologic Problems 
Sarah B. Zerhusen 
University of Kentucky, sabvol@gmail.com 
Follow this and additional works at: https://uknowledge.uky.edu/dnp_etds 
 Part of the Dermatology Commons, Family Practice Nursing Commons, Interprofessional Education 
Commons, and the Psychiatric and Mental Health Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Zerhusen, Sarah B., "Assessment of the Need for Provider Education on Screening for Depression in 
Patients with Select Dermatologic Problems" (2018). DNP Projects. 190. 
https://uknowledge.uky.edu/dnp_etds/190 
This Practice Inquiry Project is brought to you for free and open access by the College of Nursing at UKnowledge. It 
has been accepted for inclusion in DNP Projects by an authorized administrator of UKnowledge. For more 
information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my DNP Project is my original work. Proper attribution has been given to all 
outside sources. I understand that I am solely responsible for obtaining any needed copyright 
permissions. I have obtained and attached hereto needed written permission statements(s) 
from the owner(s) of each third‐party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine). 
I hereby grant to The University of Kentucky and its agents a royalty-free, non-exclusive and 
irrevocable license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless a preapproved embargo applies. I also 
authorize that the bibliographic information of the document be accessible for harvesting and 
reuse by third-party discovery tools such as search engines and indexing services in order to 
maximize the online discoverability of the document. I retain all other ownership rights to the 
copyright of my work. I also retain the right to use in future works (such as articles or books) all 
or part of my work. I understand that I am free to register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Assistant Dean for MSN and DNP Studies, on 
behalf of the program; we verify that this is the final, approved version of the student's DNP 
Project including all changes required by the advisory committee. The undersigned agree to 
abide by the statements above. 
Sarah B. Zerhusen, Student 
Dr. Nancy S. Kloha, Advisor 
Running Head: NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  
 
 
 
 
 
 
 
 
DNP Final Project Report 
Assessment of the Need for Provider Education on Screening 
 for Depression in Patients with Select Dermatologic Problems. 
 
 
Sarah B. Zerhusen, BS, BSN, RN 
 
 
University of Kentucky 
College of Nursing 
Spring, 2018 
 
 
 
 
 
 
Nancy S. Kloha DNP, APRN, FNP-BC – Committee Chair 
Elizabeth G. Tovar, PhD, APRN – Committee Member 
Joseph F. Fowler, Jr., MD – Committee Member/Clinical Mentor 
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION    
Dedication 
 This manuscript and my DNP project is dedicated to my husband, who has always given 
me love and support, especially when I have felt discouraged by the demands of this program. 
This is for everything he has selflessly put on hold in his professional career in order for me to 
achieve my dream of being a nurse practitioner. This is for my children, Jack and Evelyn, 
whopush me every day to be the best that I can be for them and give me more strength than they 
will ever know. This is for my parents who instilled in me the importance of education and hard 
work and have been my biggest cheerleaders my entire life. This is for my sister who just 
understands me and is always there for a good vent session. This is for my father-in-law, mother-
in-law, and sister-in-law who have given countless hours of their time to cooking, cleaning, and 
free babysitting so I could escape and get some work done. This is for my friends who have been 
there for the entire ride and always know when I need a night out. This is for my fellow 
classmates, especially Emily, Katherine, and Kandace. Your words of support, encouragement, 
and humor kept me going through the most challenging points of this program. This is for all the 
working mommas out there who dream of higher education. With a little hard work and 
determination you can achieve your goal.
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  
   
iii 
Acknowledgements 
 
   I would like to express my appreciation and thanks to my advisor, Dr. Nancy 
Kloha, who has become much more than an academic mentor to me over the last five years. Dr. 
Kloha, you have not only counseled me through this doctoral program, but you have also 
supported me through career changes, buying a house, and the birth of my two children. You 
have gone above and beyond as an advisor and I will always be grateful for your warmth and 
kindness. I would also like to thank Dr. Elizabeth Tovar and Dr. Joseph Fowler for taking the 
time to serve on my project committee. Dr. Tovar, you not only served as a valuable member of 
my committee, but you also taught me so many of the skills and knowledge I need to serve as a 
DNP prepared nurse. Without your thorough training I would not be the clinical student I am 
today. Dr. Fowler, as my clinical mentor your vast knowledge and experience were invaluable to 
me through this process. I have learned everything I know about chronic skin conditions and 
clinical research from you and I am forever grateful for your guidance. I appreciate you taking 
time out of your busy schedule to serve on my committee. 
 I would also like to say thank you to other members of the University of Kentucky 
College of Nursing who supported me throughout this process. Dr. Chizimuzo Okoli, thank you 
for sharing your immense knowledge of research and for always giving thoughtful and 
constructive feedback. You not only took my little idea and helped me mold it into a meaningful 
project but you also took the time to assist in the development of my questionnaire so I could 
obtain accurate and meaningful data. I would also like to thank Dr. Amanda Wiggins, whose 
knowledge of statistics is astounding. I would not have any meaningful results without her. And 
finally, I would like to thank Kathy Collins, who keeps us organized and always has the answers 
to our never-ending questions. 
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  
   
iv 
Table of Contents 
Acknowledgements ........................................................................................................................ iii 
List of Tables ................................................................................................................................. vi 
List of Figures ................................................................................................................................ vi 
Abstract ........................................................................................................................................... 1 
Introduction ..................................................................................................................................... 2 
Background ..................................................................................................................................... 3 
Purpose ............................................................................................................................................ 7 
Methods .......................................................................................................................................... 8 
Setting ................................................................................................................................................................................................. 8 
Sample ................................................................................................................................................................................................ 9 
Questionnaire .................................................................................................................................................................................. 9 
Data Collection ............................................................................................................................................................................ 12 
Data Analysis ................................................................................................................................................................................ 12 
Results ........................................................................................................................................... 14 
Sample Characteristics ............................................................................................................................................................ 14 
SBIRT in Practice ........................................................................................................................................................................ 14 
Demographic affect on screening practices ................................................................................................................... 15 
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control ........................................................... 16 
Confidence ..................................................................................................................................................................................... 16 
Barriers to intervention .......................................................................................................................................................... 17 
Evaluation of the Survey ......................................................................................................................................................... 18 
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  
   
v 
Discussion ..................................................................................................................................... 19 
SBIRT in practice ........................................................................................................................................................................ 19 
Demographic affect on screening practices ................................................................................................................... 20 
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control ........................................................... 21 
Barriers to intervention .......................................................................................................................................................... 22 
Limitations .................................................................................................................................................................................... 23 
Recommendations for future studies ................................................................................................................................ 24 
Conclusion .................................................................................................................................... 25 
References ..................................................................................................................................... 36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  
   
vi 
List of Tables 
Table 1: Table of Study Measures..................................................................................................26 
Table 2: Demographic Characteristics..........................................................................................27 
Table 3: Associations among demographic characteristics and screening for depression...........27 
Table 4: Association among provider knowledge, attitudes, perceptions, skills, and self-efficacy  
 and screening for depression.............................................................................................28 
 
 
List of Figures 
Figure 1. The Theory of Planned Behavior....................................................................................29 
Figure 2: Survey for Clinicians......................................................................................................30
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  1  
Abstract 
 
PURPOSE: The purpose of this project is to evaluate the knowledge, attitudes, perceptions, 
skills, and self-efficacy of dermatology providers’ assessment of depression in patients with 
chronic skin disease to determine the need for continuing education programs. 
METHODS:  This is a single practice, multi site, quantitative correlational design study to 
assess provider use, comfort, and proficiency of screening and discussion of depression in 
patients suffering from plaque psoriasis and atopic dermatitis. Data was collected through the use 
of a questionnaire dispensed in January of 2018. The sample consisted of 23 dermatology 
providers in a dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and 
Shelbyville, Kentucky as well as New Albany, Indiana.  
RESULTS: No statistical differences were seen in demographics, attitudes, perceived behavioral 
control, confidence, and barriers between providers who screen and those who do not screen. 
However, the 12 providers in the screening group and the 5 providers in the non-screening group 
showed significant difference in intention (p=.02) as well as subjective norms (p=.04) scores in 
the assessment of the theory of planned behavior. In addition, all 17 providers who participated 
in the study indicated the lack of training in the screening for and discussion of depression in the 
dermatology setting  
CONCLUSION: Insight into the factors that influence the practice of screening for depression in 
patients with skin disease can lead to understanding the educational needs of the dermatology 
provider. In the future, additional research needs to be completed to better understand what 
topics should be included in educational programs. The primary goal of this research is to 
increase the number of dermatology patients who benefit from a more holistic method of care. 
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Introduction 
 
 Dermatological disorders can affect a patient’s appearance, social interactions, emotions 
and day-to-day life more negatively than many other chronic diseases (Safikhani, Sundaram, 
Bao, Mulani, & Revicki, 2013; Chren, Lasek, Quinn, Mostow, & Zyzanski, 1996). Patients with 
skin disease can have low self-esteem, impaired self-image, embarrassment, sexual dysfunction 
and impaired coping practices due to obvious changes in physical appearance (Kemmerling, 
2013). In addition, certain symptoms of chronic skin disease may also lead to depression and/or 
decreased quality of life (QOL; Ando et al., 2006). Symptoms of skin disease can include severe 
dryness, pruritus (severe itching), sensitivity and pain caused by irritated lesions (National 
Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015; Peters, 2016). The National 
Psoriasis Foundation (NPF; 2015) estimates that 7.5 million Americans endure psoriasis while 
the National Eczema Association (NEA; 2014) approximates 31.6 million Americans have 
chronic dry skin, also known as atopic dermatitis and/or eczema. Collectively, these numbers 
account for almost 12.5% of the American population that suffer from eczema and psoriasis 
alone.  
 Researchers have discovered that the prevalence of depression in the general United 
States population is 6-8% while the frequency of depression in patients with skin disease can 
range from 21% to as high as 62% (Picardi et al, 2004; Esposito, Saraceno, Giunta, Maccarone, 
& Chimenti, 2006).  However, there is speculation that dermatology providers are not consistent 
in their analysis and detection of depression in patients with skin disease (Sampogna, Picardi, 
Melchi, Pasquini, & Abeni, 2003).  In a study comparing dermatology providers’ opinions of the 
prevalence of psychological co-morbidity in their patient population compared to the actual data 
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collected from the patient, Sampogna et al. (2003) found that dermatologists believe depression 
and decreased QOL are less frequent in patients with skin disorders than is actual.  
 To address possible inconsistencies in screening for and treating depression in patients 
with plaque psoriasis and atopic dermatitis, an evaluation of the current state of mental health 
assessment by dermatology providers must first be completed. Using a screening questionnaire, 
this project evaluates the provider use, comfort, and proficiency in screening for and discussion 
of depression in a dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and 
Shelbyville Kentucky as well as New Albany Indiana. The result of this assessment will provide 
information concerning the ability of the clinic providers to screen for and intervene in 
depression in patients with plaque psoriasis and atopic dermatitis. It will also determine if 
provider education is needed as a means to improve patient care. 
Background 
 
According to the American Psychological Association (APA), depression is defined as, 
“More than just sadness. People with depression may experience a lack of interest and pleasure 
in daily activities, significant weight loss or gain, insomnia or excessive sleeping, lack of energy, 
inability to concentrate, feelings of worthlessness or excessive guilt and recurrent thoughts of 
death or suicide.” (APA, 2015). The World Health Organization (WHO) states depression 
accounts for 4.3% of the global burden of disease and is the largest cause of disability worldwide 
(WHO, 2013). According to the CDC, the economic impact of depression in the U.S., which 
includes workplace costs, direct costs, and suicide, was $210.5 billion in 2010 (CDC, 2016). In 
addition, depression is also known to coincide with serious medical illnesses such as cancer, 
diabetes and skin disease (The National Institute of Mental Health (NIMH), 2016).  
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It is estimated that between 35%-50% of patients with depression receive no treatment 
due to poor screening practices and insufficient referral to mental health providers (WHO, 2013).  
In January 2016, the United States Preventive Services Task Force (USPSTF) released an official 
recommendation stating the need for all adult patients to be screened for depression in the 
primary care setting (USPSTF, 2016). The document states that screening should be performed 
in order to “ensure accurate diagnosis, effective treatment, and appropriate follow up” (USPSTF, 
2016, p. 380).  Therefore, it may be important that patients suffering from skin disease are 
assessed for depression in the dermatology setting; especially since a dermatology provider is the 
first and perhaps only medical professional many of these patients see on a regular basis (Peters, 
2016).  
 Psoriasis and atopic dermatitis are considered psychodermatological disorders because 
they are triggered and exacerbated by psychological stress (Koo & Lee, 2003; Jefferany, 2011; 
Peters, 2016). The relationship between skin disease and depression can be characterized as 
bidirectional due to the fact that depression activates a lesion flare and the presence of skin 
lesions exacerbates feelings of depression (Pietrzak et al, 2017).  Both psoriasis and atopic 
dermatitis are caused by the immune-mediated release of inflammatory cytokines in the 
epidermal layer of the skin initiating the development of skin lesions (NPF, 2015; NEA, 2015; 
Tohid, Aleem, & Jackson, 2016; Peters, 2016). Psoriatic lesions are frequently located on the 
elbows, knees, scalp, or lower back and are characterized by raised, red patches covered with 
silver/white “scales” or dead skin cells (NPF, 2015). Atopic dermatitis lesions are red, dry 
patches most often located on the arms, legs, and cheeks (NEA, 2015). Patients who suffer from 
these skin diseases experience impaired self –image, social embarrassment, and severe itching, 
also known as pruritus, which can lead to cracking, bleeding, pain, and insomnia (Kemmerling, 
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2013; NEA, 2015; NPF, 2015).  A vicious cycle is created when depression and stress perpetuate 
skin disease, leading to itching, insomnia, and social isolation, which ultimately triggers 
increased severity of skin lesions through continued exacerbation of stress pathways (Gupta & 
Gupta, 2003; Jefferany, 2011; Gordon-Elliot & Muskin, 2013; Peters, 2016; Pietrzak et al, 2017).  
 Early detection and diagnosis of depression is not only important to proper management 
of the skin disease (Bashir, Dar, & Rao, 2010; Jefferany, 2011; Peters, 2016), but it is also 
important to the management of other possible comorbidities (Egeberg, Khalid, Hilmar Gislason, 
Mallbris, Skov, & Riis Hansen, 2016). In a case-control study, Egeberg et al (2016) found that 
untreated depression in patients with psoriasis can be associated with an increased risk of 
myocardial infarction, stroke, and cardiovascular death. Therefore, proper detection of 
depression can be important to prompt discussion or early referral to a provider that can treat 
depression, leading to timely treatment of psychological co-morbidities (Richards, Fortune, 
Weidmann, Sweeney, & Griffiths, 2004).  Effective treatment by a trained primary care or 
mental health provider paired with successful care by a certified dermatology physician or 
advanced practice provider (APP) can eventually lead to a more holistic, successful, and cost-
effective treatment of skin disease and may therefore lead to decreased cardiovascular risk 
(Egeberg et al, 2016; Richards et al, 2004; NIMH, 2016; Peters, 2016). In a randomized control 
trial, Schmitt et al (2014) discovered that patients suffering from psoriasis and depression 
benefitted from interdisciplinary care when compared to those that received dermatological care 
alone, as indicated by increased QOL scores. 
 Nevertheless, depression in patients with skin disease goes unrecognized due to improper 
screening measures (Picardi et al, 2004; Peters, 2016), inaccurate perception of psychiatric 
morbidity (Sampogna et al, 2003), and the dermatology provider’s assumption that the severity 
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of disease indicates the level of depression risk (Gupta & Gupta, 2003; Cohen, Martires, & Ho, 
2015). Furthermore, although the psychocutaneous aspects of psoriasis and atopic dermatitis are 
becoming more accepted in the academic world, many dermatology providers still hold the 
misconception that successful treatment of the skin disease indicates successful treatment of the 
psychological co-morbidity (Richards et al, 2004; Kemmerling, 2013). For example, Richards et 
al (2004) discovered that when dermatology providers identified patients as being depressed it 
was only addressed during the visit in 1/3 of the cases and a referral was made to a mental health 
service in only one of the cases examined. In this study, the providers suggested the belief that if 
they controlled the patient’s psoriasis properly the depression symptoms would also disappear 
(Richards et al, 2004). Other barriers to appropriate screening practices include time restraints 
during the clinic visit, fear of stigmatizing patients, and difficulties with patient-provider 
communication of depression (Richards et al, 2004).  
 For the past twenty years, research to address this problem has focused on methods for 
quick and accurate detection of depression in the patient with skin disease through the use of 
screening tools. Tools such as the General Health Questionnaire (GHQ-12), Primary Care 
Screener for Affective Disorders (PC-SAD), Patient Health Questionnaire (PHQ), 
Psychosomatic Scale for Atopic Dermatitis; PSS-AD, ShortForm36, and Skindex, have all been 
used to help assess level of depression in patients with skin disease. However, consensus on a 
gold standard screening tool has not been accomplished so clinical practice guidelines for the 
screening of depression in patients with skin disease have not been created. In addition, there is 
concern that if a gold standard screening tool were selected, many dermatology providers may 
not use such a tool because they may lack the proper training to discuss depression with their 
patients (Richards et al., 2004; Johnson et al., 2014; Kemmerling, 2013). Therefore, an 
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evaluation of the knowledge, attitudes, perceptions, skills, and self-efficacy of depression and 
QOL will be important to understand dermatology providers’ perceptions on whether they are 
properly equipped to screen for and engage in discussions about depression with their patients. 
The results of this evaluation are expected to determine if provider education focused on proper 
screening for and discussion of depression is warranted in the treatment of patients with plaque 
psoriasis and atopic dermatitis in the dermatology setting. 
Purpose 
 
 The purpose of this project is to evaluate the knowledge, attitudes, perceptions, skills, and 
self-efficacy in assessing for depression among patients by dermatology providers in a 
dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and Shelbyville, Kentucky 
as well as New Albany, Indiana in order to determine the need for continuing education 
programs.  
 Proper screening of depression by dermatology providers is important to achieving 
holistic care of patients suffering from plaque psoriasis and atopic dermatitis. By evaluating the 
knowledge, attitudes, perceptions, skills, and self-efficacy of depression screening in 
dermatology providers, the need for provider education can be determined. Specifically this 
project has two objectives. The first objective is to determine if there is relationship between 
provider demographic data and practice of screening for depression in patients with chronic skin 
disease. Demographic measures assessed in the survey include age, gender, ethnicity, job title, 
and work tenure. Understanding the association between demographic data and screening 
practices may open the door to understanding what age, gender, ethnicity, discipline, or level of 
experience is comfortable with screening for depression while also determining those levels that 
may benefit from education in the future. 
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 The second objective of this project is to determine how provider behavioral intention, 
provider attitude, subjective norms, perceived behavioral control, use of SBIRT (Screening, 
Brief Intervention, and Referral to Treatment), provider confidence, and performance barriers 
can affect the practice of screening for depression in patients with chronic skin disease by 
dermatology providers. It is the hope that understanding these variables’ effects on screening for 
depression in patients with skin disease can help guide the development of educational courses 
on screening for depression.  
Methods 
 
 This is a single practice, multi site, quantitative correlational design study to assess 
provider use, comfort, and proficiency of screening for and discussion of depression in patients 
suffering from plaque psoriasis and atopic dermatitis. Data was collected through the use of a 
questionnaire assessing knowledge, attitudes, perceptions, skills, and self-efficacy of screening 
for depression. The questionnaire was dispensed in January 2018 to twenty-three providers 
currently practicing at a dermatology clinic with locations in Louisville, Lebanon, Leitchfield, 
and Shelbyville, Kentucky as well as New Albany, Indiana. Questionnaires were reviewed and 
data analysis was completed using the SPSS statistical software in February of 2018.  
Setting 
 
 The study site is comprised of seven clinic locations with three in Louisville, Kentucky, 
one in Lebanon, Kentucky, one in Leitchfield, Kentucky, one in Shelbyville, Kentucky, and one 
location in New Albany, Indiana. The providers include sixteen physicians, three nurse 
practitioners, and four physicians assistants. Services provided by the practice include general 
dermatology, cosmetic dermatology, and Mohs micrographic surgery. The mission of the 
practice “encompasses three arenas of excellence and advancement in the provision of 
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dermatologic care in Louisville, Kentucky and it’s surrounding regions: Service to patients, 
Education, and Leadership” (AID, 2017).  
Sample 
 
 The convenience sample participants for this evaluation are current providers of services 
at the practice. There are now 23 providers in the practice with ages ranging from approximately 
30-65 years of age. Of the current providers there are five male and eighteen female providers. 
Inclusion criteria for participation in this study included; providers who give care at any of the 
seven locations in Kentucky and Indiana, board certified physicians, advanced practice nurse 
practitioners (APRNs), and certified physician assistants (PA-C). Exclusion criteria blocking 
participation in this study included; medical students, nurse practitioner students, research 
physicians, dermopathologists, registered nurses, and medical assistants. 
Questionnaire  
 
 A questionnaire assessing the knowledge, attitudes, perceptions, skills, and self efficacy 
of depression screening was developed for data collection (Figure 1). This questionnaire was 
adapted from an already existing document used in a previous study to assess primary care 
providers’ knowledge, attitudes, perceptions, skills, and self-efficacy of discussing smoking 
cessation with patients in the clinical setting (Okoli, Otachi, Kaewbua, Woods, and Robertson, 
2017). The questionnaire was developed based on Icek Ajzen’s (2011) work on how to construct 
a questionnaire based on the theory of planned behavior. With Okoli et al.’s approval, their 
questionnaire was used as a template for the construction of the questionnaire for this study. 
Changes were made in order to fit the study topic of screening for depression in patients with 
chronic skin disease. The paper survey consists of a total of 48 questions; 45 assessment 
questions and 3 survey evaluation questions. The questionnaire obtains knowledge through 
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inquiries assessing participant demographic information, the theory of planned behavior, use of 
screening, brief intervention, and referral to treatment (SBIRT), provider confidence, and 
opinions about possible barriers to intervention. 
 Demographics. Demographic variables are assessed through five questions that include 
gender, ethnicity, age, job title and work tenure. These questions will be used to determine if 
there is a correlation between demographic data and the practice of screening for depression in 
patients with skin disease. 
 Theory of Planned Behavior. The theory of planned behavior has been used to predict 
and justify behaviors in the healthcare field. According to this theory developed by Icek Ajzen, 
there is strong correlation between one’s beliefs and one’s decision to participate in a certain 
behavior (Ajzen, 1991; 2011). This questionnaire contains fifteen questions assessing the four 
components of the theory of planned behavior; behavioral intention, attitude, subjective norms, 
and perceived behavioral control. Questions assessing behavioral intention are to determine the 
provider’s readiness to perform the screening process.  Those assessing attitude are observing the 
participant’s positive or negative evaluation of screening for depression in patients with skin 
disease. Subjective norms are obtained through questions assessing the providers perception of 
significant others and/or colleagues approval or disapproval of the screening process. Lastly, 
perceived behavioral control is assessed through questions assessing the provider’s perception on 
the ease or difficulty of screening for depression in patients with skin disease. The answers to 
these questions will be used to determine if the provider’s beliefs about screening for depression 
affect the decision to practice screening in the clinic setting.  
 SBIRT. Screening, brief intervention, and referral to treatment (SBIRT) was first 
developed as a public health model to provide effective screening, secondary prevention, early 
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recognition and treatment for patients suffering from unhealthy alcohol use in the primary health 
care setting (SAMHSA, 2011).  A 2011 report released by the Substance Abuse and Mental 
Health Services Administration (SAMHSA) stated that SBIRT could be successfully 
implemented in the diagnosis and treatment of depression. In addition, a study by Dwinnells 
(2015) found that SBIRT is effective in the assessment of patients at risk for depression in the 
primary care setting. The questions focused on SBIRT assess the providers use of this evidence 
based method through three questions asking about how often they screen for depression, 
perform behavioral interventions, and refer patients to behavioral health.  
 This portion of the questionnaire also evaluates provider confidence in their skills to 
perform SBIRT through four questions evaluating confidence in screening for and discussing 
depression in the dermatology setting. Assessing use of this method by the dermatology 
providers in this study will help in the prioritization of future provider education on proper 
methods of screening for depression in the dermatology setting. SBIRT replaces Okoli et al.’s 
(2017) use of the 5 A’s (ask, advise, assess, assist arrange) of smoking cessation. The 5 A’s 
assessment tool is specific to smoking cessation, therefore the tool had to be replaced by SBIRT 
in order to make the assessment relevant to depression screening practices. 
 Barriers to Intervention. Delay of depression intervention and treatment in the 
dermatology setting can be due to patient specific, provider specific and organizational specific 
barriers to performing depression screening. The questionnaire used in this study includes 21 
questions evaluating possible barriers to screening and discussion of depression in patients with 
chronic skin disease. Possible barriers include provider views on realm of practice, confidence, 
knowledge of the referral process, patient ideas about discussion of depression in the 
dermatology setting, time constraints, protocol availability, training, and resource availability.  
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Data Collection 
 
 Approvals from the University of Kentucky Institutional Review Board (IRB), practice 
Chief Administrative Officer and practice physician in charge of research activities were 
obtained prior to the collection of data. This study is based on results from a 48-question survey 
dispensed in January of 2018. All current providers were contacted during a practice wide 
provider staff meeting on January 17th, 2018. All providers were given a copy of the cover letter 
and questionnaire. A formal informed consent process was waived per IRB approval and 
replaced with the inclusion of a cover letter describing the study activities. Participants who have 
read the cover letter and completed the questionnaire are granting consent that data may be used 
in the analysis of the research question. Participants were given two weeks to complete and 
return the survey, with a final due date of January 31, 2018. Questionnaires were collected and 
reviewed in February of 2018. Variables reviewed included demographic data (age, ethnicity, 
gender, job title, and work tenure) and outcomes variables (behavioral intention, attitude, 
subjective norms, perceived behavioral control, SBIRT in practice, confidence, and barriers 
(Table 1).   
Data Analysis 
 
 Data analysis was completed using the IBM SPSS statistical software version 22. The 
demographic characteristics of the sample were described using frequencies and percentages for 
nominal and ordinal variables (gender, ethnicity, job title) while means and standard deviations 
were used for interval/ratio variables (age and work tenure). Data to describe results for 
knowledge, attitudes, perceptions, skills, self-efficacy, and barriers were scored on a Likert scale 
to create interval/ratio levels of measurement. Analysis of this data was completed using means 
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and standard deviations with t-test and chi-square tests to determine variance. Level of 
significance will be determined using p < 0.05. 
 This study is assessing how provider demographic characteristics and personal beliefs 
affect screening for depression in practice. Therefore, outcome variables were analyzed based on 
the providers’ answer to Section C: SBIRT in practice/role, question 1 of the questionnaire, 
which assesses for the frequency of screening for depression. The question asks, “In your 
practice/role, how often do you screen for depression in patients with chronic skin disease during 
clinic visits?” The possible answers to this question are never, seldom, occasionally, and very 
often. In order to properly examine the effect of demographic and outcome variables on 
screening practice, the SBIRT data was recoded from four possible answers to two answers to 
decrease the number of values for improved analysis. Those who answered seldom or never were 
categorized as not screening for depression (0 = no) and those who answered occasionally or 
very often were categorized as participating in screening practices (1 = yes).  Please refer to 
Table 1 for a full description of study measures and statistical analysis techniques. 
 Lastly, provider feelings toward the need for future educational programs on the proper 
practice of screening for depression in patients with skin disease was determined through the 
assessment of questions 8, 17, and 18 in Section D: Barriers to intervening with patients who 
suffer from depression. Section D, question 8 asks, “ Many clinicians are willing, but are not 
properly equipped to engage in advice and/or intervention when it comes to depression.” In 
addition, question 19 states, “ There is a lack of training for clinicians to engage in discussion 
about depression in patients with skin disease” Finally, Section D, questions 18 states “There is a 
need for written protocols to document clinician responsibilities for providing discussion about 
depression in patients with skin disease.” The possible answers to these questions are Never, 
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Seldom, Occasionally, and Very Often. In order to properly examine the answers to these 
questions, the data was recoded for improved analysis from four possible answers to two 
answers. Those who answered seldom or never were categorized as answering no (0 = no) and 
those who answered occasionally or very often were categorized as answering yes (1 = yes). 
Results 
Sample Characteristics 
  
 At the time of data collection there were 23 providers practicing at the seven clinic 
locations. Three of the providers were excluded from the sample since they practice as certified 
dermopathologists and do not see patients. Another three providers chose not to participate in the 
study. At the time of collection, a total of 17 providers submitted a completed questionnaire for 
data analysis. Of the providers that participated, 5 were male (29.4%) and 12 were female 
(70.6%), with the majority identifying as White, non-Hispanic (88.2%).  Most of the participants 
were board certified physicians (64.7%) with the remainder being advanced practice providers 
(APPs), such as advanced practices nurses or physician assistants (35.2%). The mean age of 
participants is 44.6 years old with a mean practice experience of 14.2 years. Please refer to Table 
2 for a full breakdown of demographic characteristics.  
SBIRT in Practice 
 
 After recoding the data, it was found that of the 17 providers that participated in the study 
12 (70.6%) practice screening for depression in patients with skin disease while 5 (29.4%) 
providers do not practice screening for depression. Of the 12 providers that screen, only 3(25%) 
perform behavioral interventions. In order to assess for variance between performing behavioral 
interventions and not performing behavioral interventions in those providers who screen, a chi-
square test of independence was performed. It was found that this association was not 
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statistically significant with a p value of .52 (Fisher’s exact test). In addition,  8(66.7%) of the 
screening group of providers claim they will refer patients to mental health providers if they 
screen positive for depression. A chi-square test of independence showed no statistical difference 
between referral and non-referral in those providers who admit to screening for depression; 
p=.59, Fisher’s exact test. Lastly, it was discovered that only 2 (11.8%) of the providers that 
practice screening for depression implement both behavioral interventions and referral to mental 
health, completing the SBIRT process. 
Demographic effect on screening practices 
  
 It was hypothesized that provider demographic characteristics may have an affect on their 
practice of screening for depression in the dermatology clinic. In order to assess this hypothesis, 
data was analyzed through t-test and chi-square test calculations. Two separate independent 
samples t-tests were conducted to compare provider age and years of experience to screening and 
non-screening conditions. For age there was no significant difference in the scores for screening 
(M=43.4, SD=10.7) and non-screening (M=48.0, SD=7.3) conditions; p = .38. In years of 
practice there was also no significant difference seen between screening (M= 13.1, SD=10.6) and 
non-screening (M=16.8, SD=8.9) conditions; p=.51.  
 Furthermore, three separate Chi-square tests of independence were performed to 
determine relation between gender, race, and type of providers in screening practices. A higher 
percentage of women (75%) screened for depression than men (60%), however this value was 
not statistically significant; p=.60, Fisher’s exact test. In addition, 80% of white providers and 
0% of Asian providers screen for depression, yet the relation between these variables was not 
significant; p=.07, Fisher’s exact test. Lastly, 63.6% of physicians, 66.7% of APRNs, and 100% 
of PAs regularly screen for depression. The chi-square test of independence confirmed that the 
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relation between provider type and screening practice was also not significant; p=.76, Fisher’s 
exact test. Overall, there was no significant data to explain an association between provider 
demographics and screening practices. Please refer to Table 3 for all data obtained from the 
statistical analysis. 
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control 
 
 In order to assess if provider beliefs do in fact determine practice of screening for 
depression in the dermatology clinic, independent sample t-tests were used to evaluate provider 
intention, attitudes, social norms and behavioral control to screening and non-screening practices 
(Table 4). There was no statistical significance in attitudes of the screening group (M=5.2, 
SD=1.3) and non-screening group (M=3.2, SD=2.3); p=.30. Also, there was no significant 
difference between perceived behavioral control of providers who practice screening (M=4.7, 
SD=0.75) and those who do not screen (M=4.2, SD=0.89); p=.23. However, statistical 
significance was seen in the evaluation of provider intention and perception of importance of 
screening of depression through subjective norms. The 12 providers in the screening group 
(M=5.5, SD=1.3) and the 5 providers in the non-screening group (M=3.2, SD=2.3) showed 
significant difference in intention scores with a p value of .02. In addition, those providers who 
practice screening for depression (M=3.9, SD=1.1) versus those who do not screen (M=2.4, 
SD=1.8) had significant difference in subjective norms scores; p=.04. These results suggest that 
intention and subjective norms scores are higher for those providers who screen for depression in 
their current practice.  
Confidence 
 
 It was hypothesized that provider confidence in discussing and treating depression could 
have an effect on screening practices.  Those who screen for depression did have a higher mean 
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confidence score (6.8) than those providers who do not screen (4.1). An independent samples t-
test was conducted to compare confidence in screening for depression and non-screening for 
depression conditions. There was no significant difference in scores for screening (M=6.8, 
SD=1.1) and non-screening (M=4.1, SD=4.1) conditions; p=.21.  These results suggest that 
confidence in screening for depression of the dermatology provider may not have an effect on 
actual screening practice. Please refer to Table 4 for data. 
 In addition, the association between mean confidence score and performance of the 
remaining SBIRT steps, behavioral interventions and referral to a mental health provider, were 
assessed. An independent sample t-test was performed to assess confidence in performing 
behavioral interventions (M=8.0, SD=.66) and not performing behavioral interventions (M=5.5, 
SD=2.7). This analysis did not show significance between these variables; p=.14. Lastly, an 
independent samples t-test was done to compare confidence in providers who refer patients to 
mental health providers and those who do not refer to mental health providers. There was no 
significant difference in confidence scores for those who refer (M=6.7, SD=1.9) and those who 
do not refer (M=4.2, SD=3.2); p=.17. Although mean confidence scores are higher in providers 
who practice behavioral interventions and those who refer patients to mental health providers, 
this data does not show a significant association between these variables. 
Barriers to intervention 
 
 Lastly, it is thought that the existence of specific barriers in practice may determine if 
depression screening is performed by dermatology providers. In order to analyze this hypothesis 
separate independent sample t-tests were completed to compare provider barriers, patient barriers 
and system/organization barriers in screening and non-screening conditions (Table 4). There was 
no significant difference in data for provider barriers (p=.38), patient barriers (p=.17), and 
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system/organization barriers (p=.96). Please refer to table 4 for patient, provider, and 
system/organization barrier means and standard deviations. These results indicate that possible 
barriers to practice may not directly have an effect on the provider’s habit of screening for 
depression.  
 In order to assess for provider thoughts on need for education in screening for and 
discussion of depression in patients with skin disease Section D: Barriers to intervening with 
patients who suffer from depression questions 8, 17, and 18 were evaluated. Of the participants, 
11(64.7%) indicated they feel as if clinicians are willing but are not properly equipped to engage 
in advice and or intervention when it comes to depression. In addition, 13 (76.4%) of participants 
indicated the need for written protocols for screening for and discussion of depression in patients 
with skin disease. Lastly, all 17 providers indicated that they believe there is a lack of training 
for dermatology clinicians to properly engage in discussion about depression with the patients 
suffering from skin disease. These results indicate current providers feel that more provider 
education may be warranted in this subject matter. 
Evaluation of the Survey 
  
 Participants were asked to evaluate the questionnaire based on length of the survey, 
understanding of the questions, and interest in participating in this topic of research in the future. 
Many of the participants felt the questionnaire length was too long (52.9%) while the remaining 
felt it was the right amount of questions (47.1%). The majority of the providers (82.4%) did not 
have a problem understanding the questions. When it came to future participation in research on 
screening for depression in patients with skin disease, 47.1% said no to future involvement while 
52.9% said yes they would be interested in contributing if needed. In addition, 3 of the 17 
participants wrote comments about their thoughts on the questionnaire. These three participants 
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mentioned confusion of switching from negative to positive scales versus positive to negative 
scales in some of the questions.  
Discussion 
 
 This study aims to better understand how demographic characteristics, provider beliefs, 
confidence, and possible barriers to practice affect provider habit of screening for depression in 
the dermatology setting. Current literature suggests that screening for depression in patients with 
chronic skin disease can lead to more holistic care of the patient. Unfortunately, the literature 
also shows that dermatology providers are not consistently screening for depression in their 
current practice. This study is the first to assess provider knowledge, attitudes, perceptions, 
skills, and self-efficacy as a way to understand how we can improve rates of screening in the 
future. Overall, the study results and analysis do not demonstrate strong data to associate 
provider demographic characteristics, confidence, and practice barriers in the decision to screen 
for depression. However, there was statistical significance in the association between provider 
behavioral intention and subjective norms in screening practice. In other words, the data shows 
that providers who screen feel they have a professional commitment to perform a depression 
assessment. In addition, the data illustrates that providers who screen feel a level of social 
pressure to engage in screening for depression in patients with skin disease. 
SBIRT in practice 
 
 SBIRT was first developed as a tool to increase the rates of early screening, brief 
intervention and referral to treatment of patients suffering from alcohol dependence and abuse in 
the primary care setting (SAMHSA, 2011). In 2011, SAMHSA released a statement explaining 
that this method could also be implemented in the assessment of patients at risk for depression in 
the primary care setting. In this study, 70.6% of the participants admit they do screen for 
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depression in patients with chronic skin disease in their current practice. While 66.7% of the 
providers who screen state they will refer patients positive for depression to a provider who can 
properly treat depression, only 25% say they perform behavioral interventions during the clinic 
visit. Although it has been found that SBIRT has been successfully utilized to provide more 
holistic care in patients at risk for depression (Dwinnells, 2015), the participants in this study 
who actively screen for depression in patients with skin disease are not using this evidence based 
practice method to its full potential. In order to insure that all three aspects of the SBIRT model 
are performed in patients with depression in the dermatology setting an educational program 
should be developed and implemented.  
 In addition, it was seen that the mean confidence score of those who screen for 
depression was higher than the mean confidence score of those who do not screen. Confidence 
was evaluated through questions concerning the assessment for depression, discussing 
depression with patients, recommending therapy for depression, and explaining the effects of 
depression on skin health.  Although the confidence data obtained from this study is not 
statistically significant, it may help point to areas of future research on this topic. It is possible 
that education programs focused on screening for and discussion of depression in patients with 
skin disease could increase provider confidence in the topic and therefore increase the rate of 
depression screening in their practice.  
Demographic affect on screening practices 
 It was hypothesized that the provider’s demographic characteristics may have an effect 
on depression screening practices in the clinical setting and therefore determine the focus of 
provider education. When is comes to age, sex, ethnicity/race, discipline, and years of practice 
compared to screening practice the data obtained in this study was not statistically significant. 
NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION  21  
This indicates that there is no association between provider demographics and decision to screen 
in practice. However, it was seen that while 63.6% of physicians screen for depression in patients 
with skin disease as high as 83.3% of APPs (APRNs and PAs) screen for depression in their 
current practice. It is interesting that such a high percentage of APP’s already screen for 
depression in the dermatology setting. Although this data is not significant, it may help point to 
topics of future research. Perhaps understanding the differences between MD versus APRN/PA 
training, goals of care, or methods of practice in the dermatology setting could assist in the 
development of future educational programs on screening for depression in patients with skin 
disease. 
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control 
 
 The theory of planned behavior is used to predict and justify behaviors in the healthcare 
field based on the idea that there is correlation between one’s beliefs and decision to participate 
in a certain behavior (Ajzen, 1991; 2001). There are four components of this theory; behavioral 
intention, attitude, subjective norms, and perceived behavioral control (Ajzen, 1991; 2001). 
According to Ajzen (1991), high intention scores usually lead to the performance of the 
behavior. However, there are circumstantial limitations or barriers that stop the evolution from 
high intention to implementation of the specific behavior (Ajzen, 1991; 2001). In the case of 
provider practice of screening for depression in patients with skin disease, perhaps lack of 
knowledge, skills, confidence, and self-efficacy acts as a circumstantial limitation to the 
performance of the screening behavior. Therefore, provider education on proper SBIRT practices 
and initiating discussion about depression could serve as a method to reduce the barriers to 
performing screening for depression in patients with skin disease. Please refer to Figure 1 for a 
visual description of the Theory of Planned Behavior. 
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 In this study, there was significant association between behavioral intention and 
subjective norms scores in a provider’s decision whether or not to screen for depression in 
patients with skin disease. The providers’ mean behavioral intention score, or readiness to 
perform depression screening in the dermatology setting, was significantly higher in participants 
who currently screen for depression. In addition, the mean subjective norms score, or the 
provider’s perception of their significant others/colleagues approval of the screening process, 
was significantly higher in the screening group than the non-screening group. These figures 
indicate that those who have a strong professional commitment and feel social pressure from 
significant others and colleagues are more likely to screen for depression. Attitude and perceived 
behavioral control scores were also higher in the providers who screen for depression, however 
this data was not significant.  
 The data obtained from this study is in accordance with the ideas of Ajzen’s Theory of 
Planned Behavior. In the theory, high levels of attitude, subjective norms and perceived 
behavioral control cause high intention. Subsequently, high intention scores lead to performance 
of the behavior. This data could be used to demonstrate the importance of using the Theory of 
Planned Behavior to guide the development of future educational programs on how to screen for 
and discuss depression in the dermatology setting. Educational programs can be used as a 
method to decrease circumstantial barriers through an increase in provider knowledge, skills, 
confidence, and self-efficacy. 
Barriers to intervention 
 
 Barriers to screening and intervention in patients with skin disease who suffer from 
depression can be caused by provider, patient and system/organization specific causes. Some of 
these barriers include provider comfort, visit time constraints, fear of stigmatizing patients, 
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available resources, and difficulties engaging in patient/provider education (Richards et al, 
2004). In this study, mean scores for provider, patient and system/organization barriers were 
nearly identical between groups. In addition, there was no significant data to indicate that 
possible barriers have an effect on a provider’s practice of screening for depression in patients 
with skin disease.  
 However, this section of the questionnaire did provide insight to provider thoughts about 
the need for educational programs and practice guidelines when it comes to screening for 
depression in the clinical setting. The majority of the study participants indicated the belief that 
clinicians are not properly equipped to engage in discussion about depression. Furthermore, 
94.1% of participants specified the need for written protocols and/or clinical practice guidelines 
when it comes to screening for and discussion of depression in patients with skin disease. And 
most importantly, all 17 providers indicated the lack of training in the screening for and 
discussion of depression in the dermatology setting. This data illustrates that providers who 
participated in this study may be open to not only receiving education on screening for and 
discussion of depression in patients with skin disease but also to using protocols to guide 
screening, referral and treatment of these patients. 
Limitations 
 
 Several limitations were identified in the design of this study. The sample size was small 
(n=17) making it difficult to ensure a representative distribution of the findings. In addition, 
although the data was collected from multiple sites, it was representative of a single clinical 
practice, further limiting the generalization of the results. Also, a possible limitation is 
imbalanced interpretation of inquiries in the questionnaire by the research participants. For 
example, the majority of questions were asked on a Likert scale with the lower score indicating 
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the negative answer while the higher score indicated the positive. In section B of the 
questionnaire there are two questions reversing the scale, which may have caused some 
confusion and therefore inaccurate answers. The length of the questionnaire (48 questions) can 
also serve as a limitation due to the possibility that the participants hurried to answer all the 
questions in order to return to their normal duties. Lastly, data collected via questionnaire is self-
reported data, which is infrequently independently verified and can contain sources of responder 
bias. 
Recommendations for future studies 
 Recommendations for future studies include continued assessment of provider 
knowledge, attitudes, perceptions, skills, and self-efficacy of screening for depression in the 
dermatology setting using a larger sample size in order to better capture the impact of these 
variables on actual screening practice. Once stronger data is collected, educational programs on 
screening for and discussion of depression in patients with skin disease can be created with the 
goal of improving provider confidence in caring for these patients. In addition, this data could 
aid in the development of clinical practice guidelines on screening, discussion, and referral of 
patients with chronic skin disease who also suffer from depression. Finally, pre-test/post-test 
studies should be performed after proper education and or guideline implementation. It has 
already been discovered that early detection of depression as a comorbidity and prompt 
interdisciplinary care by the dermatology and mental health provider signifies improved QOL in 
patients with skin disease. Future research should be focused on how dermatology provider 
screening and referral practice can be expanded in order to increase the number of patients who 
are properly treated for their concurrent skin disease and depression. 
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Conclusion 
 
 This study is the first to assess provider knowledge, attitudes, perceptions, skills, and 
self-efficacy as a way to understand how we can improve rates of screening for depression in the 
future. Data obtained from this analysis was used to determine what additional provider 
education is needed in order to increase the incidence of screening for and discussion of 
depression in the dermatology setting. The majority of participants (70.6%) do actively screen 
for depression in their daily practice. However, the data suggests that many of the providers are 
not utilizing all aspects of the SBIRT model in the assessment of patients with possible 
depression. Unfortunately, no statistical significance was found to associate provider 
demographic characteristics, confidence, and practice barriers in the decision to screen for 
depression. Yet, there was statistical significance in the association between provider behavioral 
intention and subjective norms in screening practice. In addition, all 17 providers indicated the 
need for education on screening for depression in the dermatology setting. Therefore, the data 
obtained from this study concerning SBIRT, the theory of planned behavior, and provider 
thoughts on the lack of instructional programs demonstrates the need for continuing education on 
depression screening for dermatology providers. In the future, additional research needs to be 
completed in order to better understand what topics should be included in educational programs. 
The primary goal of this research is to increase the number of dermatology patients who benefit 
from a more holistic method of care. 
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Table 1. Table of Study Measures 
 
Table of Study Measures 
Measures Description Level of Measurement Analysis Data Source 
Demographics 
Gender Male vs. Female Nominal Frequencies, Chi-square Questionnaire 
Ethnicity White, Black, Hispanic, 
Indian, Native American, 
Middle Eastern, Mixed Race, 
Asian, Other 
Nominal Frequencies, Chi-square Questionnaire 
Job title MD, APRN, or PA Nominal Frequencies, Chi-square Questionnaire 
Age Age in years Interval/ratio Means (SD), t-tests Questionnaire 
Work tenure Length of time at job in years Interval/ratio Means (SD), t-tests Questionnaire 
Outcome 
Intention Provider intent to perform 
depression screening in 
patients with skin disease is 
assed by assessing if the 
expect to screen, want to 
screen and intent to screen 
Interval/Ratio Mean (SD), t-tests Questionnaire 
Attitude Providers are asked on a scale 
of 1 to 7 if screening for 
depression is 1) harmful-
beneficial 2) good-bad 3) 
Pleasant for you-Unpleasant 
for you 4) worthless-useful to 
their practice. 
Interval/Ratio Mean (SD), t-tests Questionnaire 
Subjective Norms Providers are asked if 1) 
people important to them 2) it 
is expected of them 3) under 
social pressure 4) expected 
from peers to perform 
screening on patients with 
skin disease. 
Interval/Ratio Mean (SD), t-tests Questionnaire 
Perceived Behavioral Control Providers are asked perceived 
behavioral control of the 
performance of depression 
screening in patients with 
skin disease based on  
1) Level of confidence in 
performing the task, 2) 
difficulty of providing 
screening, 3) believe decision 
beyond their control, and 4) 
believe the decision to 
provide screening is in their 
control. 
Interval/Ratio Mean (SD), t-tests Questionnaire 
SBIRT in Practice Providers are asked how often 
(never, seldom, often, always) 
they perform the following 
tasks in their practice role 1) 
Screening for depression 2) 
Behavioral Intervention for 
those with depression 3) 
Referral to Behavioral Health 
Treatment 
Interval/Ratio Mean (SD) Questionnaire 
Confidence Providers asked on scale of 1-
10 rate confidence of current 
skills to 1) determine degree 
of depression in patients 2) 
Discuss depression with 
patients 3) Recommend 
therapy for depression 4) 
Explain effects of depression 
on skin health 
 
Interval/Ratio Mean (SD), t-tests Questionnaire 
Barriers Provider asked if they 
completely disagree, 
somewhat disagree, 
somewhat agree, or 
completely agree with listed 
provider specific, patient 
specific and system specific 
barriers to depression 
screening in the dermatology 
setting. 
Interval/Ratio Mean (SD), t-tests Questionnaire 
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Table 2. Demographic Characteristics  
Demographic Characteristics 
Characteristic n (%) 
Age, years Mean (SD) 44.6 (9.8) 
Sex 
      Male 
     Female 
 
5 (29.4%) 
12 (70.6%) 
Ethnicity/Race 
    White, non-Hispanic 
    Black, non-Hispanic 
   Hispanic 
  Asian, Pacific Islander 
 
15 (88.2%) 
0 (0%) 
0 (0%) 
2 (11.8%) 
Discipline 
    Physician (MD) 
   Physician (DO) 
  Advanced Practice Nurse (APRN/CNS) 
 Physician Assistant (PA) 
 
11 (64.7%) 
0 (0%) 
3 (17.6%) 
3 (17.6%) 
Years of practice, mean (SD) 14.2 (10.04) 
Notes: Standard Deviation (SD) 
 
Table 3. Associations among demographic characteristics and screening for depression 
Demographic 
Characteristic 
Yes (n=12) 
 
Mean (SD) or n (%) 
No (n=5) 
 
Mean (SD) or n (%) 
p 
Age 43.3 (10.7) 48.0 (7.3) .38 
Gender 
   Male 
   Female 
 
3 (60.0%) 
9 (75.0%) 
 
2 (40.0%) 
3 (25.0%) 
 
.60 
Race 
   White 
   Asian 
 
12 (80%) 
0 (0.0%) 
 
3 (20%) 
2 (100%) 
 
.07 
Type of provider 
    MD 
   APRN 
  PA 
    
 
7 (63.6%) 
2(66.7%) 
3 (100%) 
 
4 (36.4%) 
1 (33.3%) 
0 (0.0%) 
 
 
.76 
Years of experience 13.1 (10.6) 16.8 (8.9) .51 
Notes: Standard Deviation (SD), Physician (MD), Advanced Practice Nurse (APRN), 
 Physician Assistant (PA) 
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Table 4. Association among provider knowledge, attitudes, perceptions, skills, and self-efficacy 
and screening for depression 
 Yes (n=12) 
 
Mean (SD)  
No (n=5) 
 
Mean (SD)  
p 
Intention 5.5 (1.3) 3.2 (2.3) .02 
Attitudes 5.2 (1.1) 4.5 (1.6) .30 
Subjective Norms 3.9 (1.1) 2.4 (1.8) .04 
Perceived Behavioral 
Control 
 
4.7 (0.75) 
 
4.2 (0.89) 
 
.23 
Confidence 6.8 (1.1) 4.1 (4.1) .21 
Provider Barriers 2.2 (.44) 2.4 (.52) .38 
Patient Barriers 2.4 (.40) 3.1 (.82) .17 
System/Organization 
Barriers 
 
3.3 (.33) 
 
3.3 (.56) 
 
.96 
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Figure 1. The Theory of Planned Behavior 
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Figure 2. Survey for Clinicians 
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